DermNet provides Google Translate, a free machine translation service. Note that this may not provide an exact translation in all languages
Authors: Vanessa Ngan, Staff Writer, 2003. Updated: Dr Maanasa Bandla, Intern, Monash Health, Melbourne, Australia; Dr Martin Keefe, Dermatologist, Christchurch, New Zealand. Copy edited by Gus Mitchell. August 2021
Folliculitis decalvans is a chronic, neutrophilic inflammation that results in scarring hair loss. Tufted hair folliculitis is probably a subset of folliculitis decalvans although tufting can be seen in other forms of cicatricial alopecia as well.
Folliculitis decalvans usually presents in the 4th and 5th decades, with a male predominance. Children are not affected.
There are probably no racial differences in prevalence, although it has been claimed to be more common in African-American women.
Familial cases have been rarely reported.
Folliculitis decalvans is considered to be the result of an abnormal immune response to Staphylococcus aureus, although this is not yet proven.
Folliculitis decalvans typically affects the scalp, often around the crown, but may affect the beard area, axillae, limbs, and pubic hair. The characteristic clinical features include:
Skin biopsy of an early lesion shows a neutrophilic infiltrate dilating the infundibulum of the hair follicle. The follicle in later lesions has ruptured resulting in perifollicular scarring and mixed inflammatory infiltrate including foreign body giant cells.
Folliculitis decalvans usually follows a chronic fluctuating course of exacerbations and remissions over many years. It is not clear that treatment influences the long-term prognosis despite successfully reducing inflammation in the short-term. Early diagnosis and treatment are important but permanent hair loss is to be expected.
Books about skin diseases
© 2021 DermNet New Zealand Trust.
DermNet NZ does not provide an online consultation service. If you have any concerns with your skin or its treatment, see a dermatologist for advice.